1 of 1
Story summary
- AstraZeneca chief executive Pascal Soriot received a 6.4% pay rise last year, bringing total remuneration to £17.7 million.
- His package includes £1.5 million salary, £4.3 million in annual bonuses, and £11.6 million in long-term share bonuses.
- AstraZeneca canceled a £450 million vaccine site expansion and a £200 million research investment due to disputes over drug pricing with the government.
- Soriot aims for further increases this year.
